Pharma CI Conference & Exhibition Showcases the Intelligence Industry’s Best

Scene_1 Scene_2 Scene_3 Scene_4

Along with hundreds of attendees, the 2015 Pharma CI Conference & Exhibition held recently in Parsippany, NJ, featured more than 75 senior-level speakers, representing major pharma companies—including Merck, Bayer and Pfizer—who are driving innovation and challenging the status quo. Attendees experienced dynamic keynote sessions on a multitude of topics, such as commercial competitive intelligence and the best practices of CI outside of the pharma industry. During two days, attendees had exclusive access to the intelligence professionals who are designing the future of the industry.

A variety of focused track-based sessions also allowed attendees to customize their conference experience for learning and networking opportunities. A series of roundtable discussions gave attendees further opportunities to learn from, and interact with, the top thought leaders in competitive intelligence.

The event’s “Masterclass” workshops once again proved to be one of the most valuable portions of the conference experience. Masterclasses are held the day before the conference kicks off to give attendees an intensive workshop environment in which they can learn innovative ideas and build new relationships in an intimate setting.

For the last decade and going strong today, the Pharma CI Conference & Exhibition has been the best and largest assembly of competitive intelligences executives in the world (http://bit.ly/1Slmx5X). The 2016 conference lineup is already shaping up to be even greater, with upcoming events to be held in Hong Kong from June 14-15, and in Parsippany, NJ on September 13-14, 2016.

 

Ads

You May Also Like

Healthcare Highlights

LABEL CHANGES Over-the-counter medication labels contain a seemingly infinite amount of microscopic words that ...

Industry Briefs

GOOGLE DRUG ADS Last month, Google set aside $500 million to potentially settle a ...

Prostate Cancer

“Each year more patients present with prostate cancer at increasingly younger ages and with ...

[sam_pro id=0_12 codes="true"]
[sam_pro id=0_6 codes="false"]